ACA-28, an anticancer compound, induces Pap1 nuclear accumulation via ROS-dependent and -independent mechanisms in fission yeast

MicroPubl Biol. 2023 Aug 31:2023:10.17912/micropub.biology.000711. doi: 10.17912/micropub.biology.000711. eCollection 2023.

Abstract

The nucleocytoplasmic transport of proteins is an important mechanism to control cell fate. Pap1 is a fission yeast nucleocytoplasmic shuttling transcription factor of which localization is redox regulated. The nuclear export factor Crm1/exportin negatively regulates Pap1 by exporting it from the nucleus to the cytoplasm. Here, we describe the effect of an anti-cancer compound ACA-28, an improved derivative of 1'-acetoxychavicol acetate (ACA), on the subcellular distribution of Pap1. ACA-28 induced nuclear accumulation of Pap1 more strongly than did ACA. ROS inhibitor N-acetyl-L-cysteine (NAC) partly antagonized the Pap1 nuclear accumulation induced by ACA-28. NAC almost abolished Pap1 nuclear localization upon H 2 O 2 , whereas leptomycin B (LMB)-mediated inhibition of Pap1 nuclear export was resistant to NAC. Collectively, ACA-28-mediated apoptosis in cancer cells may involve ROS-dependent and -independent mechanisms.

Grants and funding

This study was supported by the MEXT‐Supported Program for the Strategic Research Foundation at Private Universities, 2014–2018 (S1411037), and by JSPS KAKENHI Grant Number JP19H03376 (Reiko Sugiura), JP20K07058 (Teruaki Takasaki) and JP20K06494 (Ryosuke Satoh). This work was also supported by a grant from the Antiaging Project for Private Universities (Reiko Sugiura).